Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Plos One|August 14, 2019
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015Dorthe Raben, Ann Kathleen Sullivan, Amanda Mocroft, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013, Amanda Mocroft, Jens Lundgren, et al.
AIDS (London, England)|August 24, 2022
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
The Journal of Infectious Diseases|December 11, 2012
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes, Dominique Costagliola, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|February 24, 2022
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort SettingLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Plos One|December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortiumBastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort CollaborationErich Tusch, Lene Ryom, Annegret Pelchen-Matthews, et al.
Pageof 24